Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine
The aim of the study was to detect sertraline and its metabolites in urine under standardized thin layer chromatography (TLC) screening conditions and identify the metabolites using the mass spectrometry method. Materials and methods. Urine samples, collected within 30 hours in portions of 20–50...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2024-02-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/293490/291617 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849710220936216576 |
|---|---|
| author | S. B. Baiurka S. A. Karpushyna N. M. Kosmina L. V. Krichkovskaya I. Ye. Bylov O. O. Altukhov |
| author_facet | S. B. Baiurka S. A. Karpushyna N. M. Kosmina L. V. Krichkovskaya I. Ye. Bylov O. O. Altukhov |
| author_sort | S. B. Baiurka |
| collection | DOAJ |
| description | The aim of the study was to detect sertraline and its metabolites in urine under standardized thin layer chromatography (TLC) screening conditions and identify the metabolites using the mass spectrometry method.
Materials and methods. Urine samples, collected within 30 hours in portions of 20–50 mL, commenced from the seventh hour after the administration of a single therapeutic dose of the drug. The sample preparation process involved dilute acid hydrolysis, followed by the extraction of the native compound and metabolites with chloroform at a pH of 8–9. Thin layer chromatography studies of the extracts were conducted using four unified TLC systems recommended by The International Association of Forensic Toxicologists for general drug screening. Chromatograms were subjected to color reactions with a variety of chromogenic reagents. For the analysis of eluates from chromatograms, a Varian 1200 L mass spectrometer (Netherlands) equipped with a dual quadrupole mass analyzer was employed. Identification was performed through direct sample introduction into the ion chamber, electron-impact ionization (70 eV), and full ion scanning mode.
Results. The spot of the native drug on the chromatogram was identified by the Rf, value. Metabolite of sertraline was identified as N-desmethyltrihydroxysertraline by the molecular ion peak in the mass spectrum.
Conclusions. The study demonstrated the ability of TLC to detect sertraline and its metabolite, N-desmethyltrihydroxysertraline, in urine after the administration of a single therapeutic dose of the drug. The chromatographic mobility of the native compound and N-desmethyltrihydroxysertraline in the unified TLC screening systems, along with the results of their visualization using chromogenic reagents for toxicological drug screening, was determined. Furthermore, the potential of coupling TLC with mass spectrometry for the separation, detection, and confirmatory identification of sertraline and its metabolic products in urine was established. |
| format | Article |
| id | doaj-art-800539e35cb74bbd9f52753b38c07080 |
| institution | DOAJ |
| issn | 2306-8094 2409-2932 |
| language | English |
| publishDate | 2024-02-01 |
| publisher | Zaporizhzhia State Medical and Pharmaceutical University |
| record_format | Article |
| series | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| spelling | doaj-art-800539e35cb74bbd9f52753b38c070802025-08-20T03:14:58ZengZaporizhzhia State Medical and Pharmaceutical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322024-02-01171212510.14739/2409-2932.2024.1.293490Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urineS. B. Baiurka0https://orcid.org/0000-0001-7505-6322S. A. Karpushyna1https://orcid.org/0000-0001-8834-4286N. M. Kosmina2https://orcid.org/0000-0002-9334-1036L. V. Krichkovskaya3https://orcid.org/0000-0003-3136-3149I. Ye. Bylov4https://orcid.org/0000-0001-7685-465XO. O. Altukhov5https://orcid.org/0000-0001-6930-8917National University of Pharmacy, Kharkiv, UkraineNational University of Pharmacy, Kharkiv, UkraineKharkiv Scientific Research Forensic Center of the Ministry of Internal Affairs of UkraineNational University of Pharmacy, Kharkiv, UkraineNational University of Pharmacy, Kharkiv, UkraineKharkiv Scientific Research Forensic Center of the Ministry of Internal Affairs of UkraineThe aim of the study was to detect sertraline and its metabolites in urine under standardized thin layer chromatography (TLC) screening conditions and identify the metabolites using the mass spectrometry method. Materials and methods. Urine samples, collected within 30 hours in portions of 20–50 mL, commenced from the seventh hour after the administration of a single therapeutic dose of the drug. The sample preparation process involved dilute acid hydrolysis, followed by the extraction of the native compound and metabolites with chloroform at a pH of 8–9. Thin layer chromatography studies of the extracts were conducted using four unified TLC systems recommended by The International Association of Forensic Toxicologists for general drug screening. Chromatograms were subjected to color reactions with a variety of chromogenic reagents. For the analysis of eluates from chromatograms, a Varian 1200 L mass spectrometer (Netherlands) equipped with a dual quadrupole mass analyzer was employed. Identification was performed through direct sample introduction into the ion chamber, electron-impact ionization (70 eV), and full ion scanning mode. Results. The spot of the native drug on the chromatogram was identified by the Rf, value. Metabolite of sertraline was identified as N-desmethyltrihydroxysertraline by the molecular ion peak in the mass spectrum. Conclusions. The study demonstrated the ability of TLC to detect sertraline and its metabolite, N-desmethyltrihydroxysertraline, in urine after the administration of a single therapeutic dose of the drug. The chromatographic mobility of the native compound and N-desmethyltrihydroxysertraline in the unified TLC screening systems, along with the results of their visualization using chromogenic reagents for toxicological drug screening, was determined. Furthermore, the potential of coupling TLC with mass spectrometry for the separation, detection, and confirmatory identification of sertraline and its metabolic products in urine was established.http://pharmed.zsmu.edu.ua/article/view/293490/291617sertralinehydroxysertralinen-desmethyltrihydroxysertralineurinethin layer chromatographymass spectrometry |
| spellingShingle | S. B. Baiurka S. A. Karpushyna N. M. Kosmina L. V. Krichkovskaya I. Ye. Bylov O. O. Altukhov Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki sertraline hydroxysertraline n-desmethyltrihydroxysertraline urine thin layer chromatography mass spectrometry |
| title | Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine |
| title_full | Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine |
| title_fullStr | Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine |
| title_full_unstemmed | Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine |
| title_short | Coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine |
| title_sort | coupling thin layer chromatography with mass spectrometry for detection and identification of sertraline and its metabolite in the urine |
| topic | sertraline hydroxysertraline n-desmethyltrihydroxysertraline urine thin layer chromatography mass spectrometry |
| url | http://pharmed.zsmu.edu.ua/article/view/293490/291617 |
| work_keys_str_mv | AT sbbaiurka couplingthinlayerchromatographywithmassspectrometryfordetectionandidentificationofsertralineanditsmetaboliteintheurine AT sakarpushyna couplingthinlayerchromatographywithmassspectrometryfordetectionandidentificationofsertralineanditsmetaboliteintheurine AT nmkosmina couplingthinlayerchromatographywithmassspectrometryfordetectionandidentificationofsertralineanditsmetaboliteintheurine AT lvkrichkovskaya couplingthinlayerchromatographywithmassspectrometryfordetectionandidentificationofsertralineanditsmetaboliteintheurine AT iyebylov couplingthinlayerchromatographywithmassspectrometryfordetectionandidentificationofsertralineanditsmetaboliteintheurine AT ooaltukhov couplingthinlayerchromatographywithmassspectrometryfordetectionandidentificationofsertralineanditsmetaboliteintheurine |